Polyrizon (NASDAQ:PLRZ) Shares Down 4.6% – Time to Sell?

Shares of Polyrizon Ltd. (NASDAQ:PLRZ) dropped 4.6% during trading on Wednesday . The stock traded as low as $9.12 and last traded at $9.72. Approximately 33,892 shares traded hands during mid-day trading, a decline of 42% from the average daily volume of 58,792 shares. The stock had previously closed at $10.19.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the stock. Weiss Ratings lowered shares of Polyrizon from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, July 29th. Wall Street Zen raised shares of Polyrizon from a “sell” rating to a “hold” rating in a research report on Sunday, June 7th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock has an average rating of “Sell”.

Polyrizon Stock Performance

The firm has a 50 day moving average price of $12.58 and a 200 day moving average price of $13.34.

Institutional Inflows and Outflows

A hedge fund recently bought a new position in Polyrizon stock. Jane Street Group LLC purchased a new position in Polyrizon Ltd. (NASDAQ:PLRZ) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 14,032 shares of the company’s stock, valued at approximately $119,000. Jane Street Group LLC owned 1.35% of Polyrizon as of its most recent filing with the Securities and Exchange Commission.

About Polyrizon

Polyrizon Ltd. is a development stage biotech company specializing in the development of medical device hydrogels delivered in the form of nasal sprays. Polyrizon Ltd. is based in Raanana, Israel.